GPCR/G protein
GPCR/G protein(G 蛋白偶联受体/G 蛋白)
- Neuropeptide FF/AF Receptors(49)
- Formyl Peptide Receptors(11)
- 5-HT Receptor(504)
- Acetylcholine(29)
- Adenosine Deaminase(9)
- Adenosine Receptor(132)
- Adenosine Kinase(4)
- Adiponectin Receptor(3)
- Adrenergic Receptor(421)
- Adrenergic Transporters(5)
- Apelin Receptor(9)
- Angiotensin Receptor(114)
- Bombesin Receptors(23)
- Bradykinin Receptors(29)
- Calcitonin and Related Receptors(10)
- Cannabinoid Receptor(160)
- Calcimimetic Agent(2)
- CaSR(20)
- CCK1 Receptors(7)
- CCK2 Receptors(7)
- CCR(81)
- Chemokine Receptors(25)
- CRF1 Receptors(9)
- CRF2 Receptors(3)
- CXCR(80)
- CysLT1 receptor(1)
- Endothelin Receptor(52)
- EP1 Receptor(2)
- EP4 Receptor(3)
- ERRγ(1)
- ETA Receptors(5)
- ETB Receptors(5)
- Free Fatty Acid Receptors(18)
- Galanin Receptors(11)
- Ghrelin Receptors(12)
- GHSR(21)
- GIP Receptor(5)
- Glucagon Receptor(61)
- Glucocorticoid Receptor(97)
- GLUT1(1)
- Gonadotropin-Releasing Hormone Receptors(3)
- GPCR19(12)
- GPR109A(4)
- GPR119(10)
- GPR120(9)
- GPR35(10)
- GPR44(1)
- GPR55(11)
- Hydroxycarboxylic Acid Receptors(5)
- Leukotriene Receptor(58)
- LPA Receptor(12)
- LPL Receptor(60)
- LTD4 Receptor(1)
- mGluR (119)
- Melanin-concentrating Hormone Receptors(7)
- Melanocortin (MC) Receptors(58)
- Melatonin Receptors(24)
- Motilin Receptor(7)
- MT Receptor(1)
- Non-selective CRF(7)
- Neurotensin Receptors(24)
- NK2 Receptors(7)
- NK3 Receptor(6)
- NOP Receptor(20)
- NPY Receptors(28)
- Orexin(3)
- Orphan 7-TM Receptors(6)
- OX Receptor(48)
- Oxytocin Receptors(22)
- P2Y Receptor(62)
- PACAP Receptors(3)
- PAF Receptors(8)
- Peptide Receptors(14)
- PGD2 Receptor(1)
- Prostaglandin Receptor(172)
- Protease-Activated Receptors(10)
- Prostanoid Receptors
- RGS(2)
- S1P receptor(8)
- Secretin Receptors(1)
- Sensory Neuron-Specific Receptors(1)
- Somatostatin Receptor(39)
- Sigma Receptor(59)
- Vasopressin Receptor(35)
- 17,20-lyase(5)
- Ras(142)
- Urotensin-II Receptor(11)
- VIP Receptors(7)
- EBI2/GPR183(7)
- TSH Receptor(11)
- NK Receptor(1)
- GPR81(1)
- C3aR(1)
- CysLT2 receptor(1)
- S1P receptor inhibitor(22)
- CCKB(1)
- FFAR1 (GPR40)(20)
- GPR84(8)
- Neuromedin U Receptors(2)
- Kisspeptin Receptor(5)
- CRFR(25)
- RGS Protein(5)
- Urotensin Receptor(6)
- Cholecystokinin Receptor(25)
- GPR139(4)
- mAChR(185)
- MCHR1 (GPR24)(16)
- Neurokinin Receptor(75)
- Neuropeptide S Receptor(1)
- GPBA Receptor(1)
- Trace Amine 1 Receptor(2)
- GPCR protein(1)
- FFAR3(1)
- cGMP(27)
- GRK(1)
- GPR88
- Amylin Receptor
- Arrestin
- GCGR(2)
- GLP Receptor(2)
- Mas-related G-protein-coupled Receptor (MRGPR)
- Succinate Receptor 1
- PTHR(1)
- Protease Activated Receptor (PAR)(2)
- Free Fatty Acid Receptor(1)
- Formyl Peptide Receptor (FPR)(1)
GPCR/G protein 相关产品(3377)
- GC14105Alprenolol hydrochlorideCAS: 13707-88-5纯度: >98.00%
A non-selective β-AR and 5-HT receptor antagonist
- GC14112RFRP 3 (human)CAS: 311309-27-0纯度: >98.50%
RFRP-3 (Neuropeptide VF(124-131))(human) 是一种人类 GnIH 肽同源物，是一种通过抑制 Ca2+ 动员来有效抑制促性腺激素分泌的抑制剂。
- GC14167QuetiapineCAS: 111974-69-7纯度: >98.00%
Quetiapine是一种5-HT受体激动剂，对人类5-HT1A受体的 pEC 50 为4.77。Quetiapine是一种多巴胺受体拮抗剂，对人类D2受体的pIC 50 为6.33。Quetiapine是一种非典型抗精神病药，用于治疗精神分裂症、躁郁症和重度抑郁症。
- GC14195LP 12 hydrochlorideCAS: 1185136-22-4
LP 12 hydrochloride (compound 21) 是一种有效的选择性 5-HT7 受体激动剂，Ki 为 0.13 nM。
- GC14216Chlorpromazine HClCAS: 69-09-0纯度: >99.50%
Chlorpromazine HCl是一种口服有效的、可透过血脑屏障的吩噻嗪类抗精神病药，能够有效抑制D2多巴胺受体和5-HT 2A ，具有很强的镇静作用。
- GC14222[D-p-Cl-Phe6,Leu17]-VIPCAS: 102805-45-8
[D-p-Cl-Phe6,Leu17]-VIP 是一种竞争性和选择性血管活性肠肽 (VIP) 受体拮抗剂，IC50 为 125.8 nM。
- GC14266CCG 203971CAS: 1443437-74-8纯度: >99.00%
An inhibitor of the Rho/MKL1/SRF transcriptional pathway
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC14105 | Alprenolol hydrochloride | 13707-88-5 | >98.00% | |
A non-selective β-AR and 5-HT receptor antagonist | ||||
| GC14112 | RFRP 3 (human) | 311309-27-0 | >98.50% | |
RFRP-3 (Neuropeptide VF(124-131))(human) 是一种人类 GnIH 肽同源物，是一种通过抑制 Ca2+ 动员来有效抑制促性腺激素分泌的抑制剂。 | ||||
| GC14113 | Oxybutynin | 5633-20-5 | >99.50% | |
An antagonist of muscarinic acetylcholine receptors | ||||
| GC14115 | AVE-1625 | 358970-97-5 | - | |
A potent CB 1 receptor antagonist | ||||
| GC14119 | BIM 23052 | 133073-82-2 | - | |
sst5 receptor agonist | ||||
| GC14127 | MCL 0020 | 475498-26-1 | - | |
MCL 0020 是一种有效的选择性黑皮质素 MC4 受体拮抗剂，IC50 为 11.63 nM。 | ||||
| GC14128 | SC 19220 | 19395-87-0 | - | |
A selective EP 1 receptor antagonist | ||||
| GC14137 | CRF (6-33) | 120066-38-8 | - | |
CRF (6-33) 是一种 CRF 结合蛋白 (CRF-BP) 配体抑制剂。 | ||||
| GC14149 | WAY 208466 dihydrochloride | 1207064-61-6 | - | |
A selective 5-HT 6 receptor agonist | ||||
| GC14161 | WEB 2086 | 105219-56-5 | >99.00% / >99.50% / >98.00% | |
A potent, selective PAF receptor antagonist | ||||
| GC14167 | Quetiapine | 111974-69-7 | >98.00% | |
Quetiapine是一种5-HT受体激动剂，对人类5-HT1A受体的 pEC 50 为4.77。Quetiapine是一种多巴胺受体拮抗剂，对人类D2受体的pIC 50 为6.33。Quetiapine是一种非典型抗精神病药，用于治疗精神分裂症、躁郁症和重度抑郁症。 | ||||
| GC14173 | L-161,982 | 147776-06-5 | >95.00% | |
A potent, selective EP 4 receptor antagonist | ||||
| GC14177 | R-1 Methanandamide Phosphate | 649569-33-5 | - | |
A water soluble prodrug AEA analog | ||||
| GC14195 | LP 12 hydrochloride | 1185136-22-4 | - | |
LP 12 hydrochloride (compound 21) 是一种有效的选择性 5-HT7 受体激动剂，Ki 为 0.13 nM。 | ||||
| GC14198 | SDZ WAG 994 | 130714-47-5 | - | |
A1 adenosine receptor agonist | ||||
| GC14211 | ONO-8130 | 459841-96-4 | - | |
A selective, orally bioavailable EP 1 antagonist | ||||
| GC14212 | BW 245C | 72814-32-5 | >98.00% | |
A selective DP 1 receptor agonist | ||||
| GC14215 | Cevimeline | 107233-08-9 | >98.00% | |
Cevimeline是一种强效的直接作用muscarinic受体激动剂，具有口服生物利用度。 | ||||
| GC14216 | Chlorpromazine HCl | 69-09-0 | >99.50% | |
Chlorpromazine HCl是一种口服有效的、可透过血脑屏障的吩噻嗪类抗精神病药，能够有效抑制D2多巴胺受体和5-HT 2A ，具有很强的镇静作用。 | ||||
| GC14222 | [D-p-Cl-Phe6,Leu17]-VIP | 102805-45-8 | - | |
[D-p-Cl-Phe6,Leu17]-VIP 是一种竞争性和选择性血管活性肠肽 (VIP) 受体拮抗剂，IC50 为 125.8 nM。 | ||||
| GC14249 | UNC 0642 | 1481677-78-4 | >99.50% | |
A G9a histone methyltransferase inhibitor | ||||
| GC14258 | SR 27897 | 136381-85-6 | >99.00% | |
A nonpeptide CCK 1 antagonist | ||||
| GC14266 | CCG 203971 | 1443437-74-8 | >99.00% | |
An inhibitor of the Rho/MKL1/SRF transcriptional pathway | ||||
| GC14275 | MMK 1 | 271246-66-3 | - | |
An FPR2 agonist | ||||